Zura Bio Ltd (ZURA)

$3.69 +0.33 (9.82%)
Market Cap 239.92M
Revenue (ttm) 0.00
Net Income (ttm) -45.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 637,500
Avg Vol 1,948,436
Day's Range N/A - N/A
Shares Out 65.02M
Stochastic %K 64%
Beta 0.25
Analysts Strong Sell
Price Target $13.33

Company Profile

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that ne...

Industry: Biotechnology
Sector: Healthcare
Phone: 702 825 9872
Website: zurabio.com
Address:
1489 W. Warm Springs Road, Suite 110, Henderson, United States
invinc1ble
invinc1ble Oct. 25 at 3:26 PM
$ZURA sleeper. Watch it
0 · Reply
octavia8
octavia8 Oct. 14 at 2:00 PM
$ZURA v shaped recovery??
0 · Reply
jerry_berlin
jerry_berlin Oct. 13 at 3:53 PM
$ZURA why is it going down?
2 · Reply
TraderJay85
TraderJay85 Oct. 10 at 5:34 PM
$ZURA Big win! 🔥 🔥 Went to 4.58. Got in early. We had over 10 poppers so far today. If you are not hitting at least 3 runners a day, then you aint doin something right. NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 10 at 1:01 PM
$ZURA
1 · Reply
kkbb
kkbb Oct. 10 at 12:32 PM
$ZURA https://investors.zurabio.com/node/9026/html Zura Bio’s CEO, Robert Lisicki, is taking a medical leave of absence effective October 10, 2025. The company’s COO and Chief Legal Officer, Kim Davis, has been appointed interim CEO while continuing her current roles.
0 · Reply
stockthoughts9282
stockthoughts9282 Oct. 9 at 5:00 PM
I bought two shares of $ZURA last year just because I thought the name sounded funny and obviously I now wish I'd bought hundreds, because it's up 150%. What exactly do they produce or do? Can someone explain? Or is this just a pump and dump on a penny stock? Thanks.
1 · Reply
jerry_berlin
jerry_berlin Oct. 8 at 7:28 PM
$ZURA yes beauty slow and stady✨
0 · Reply
BassmanOH
BassmanOH Oct. 8 at 2:39 AM
$ZURA Complete and Utter WOW
1 · Reply
jerry_berlin
jerry_berlin Oct. 7 at 4:43 PM
$ZURA Slow and stady 🐂💚
0 · Reply
Latest News on ZURA
Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference

Aug 20, 2025, 6:30 AM EDT - 2 months ago

Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

Aug 14, 2025, 8:15 AM EDT - 2 months ago

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 17, 2025, 4:30 PM EDT - 3 months ago

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zura Bio Announces Chief Financial Officer Transition

Jul 1, 2025, 6:30 AM EDT - 4 months ago

Zura Bio Announces Chief Financial Officer Transition

Zura Bio to Present at the Jefferies Global Healthcare Conference

May 27, 2025, 6:30 AM EDT - 5 months ago

Zura Bio to Present at the Jefferies Global Healthcare Conference

Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa

May 20, 2025, 6:30 AM EDT - 5 months ago

Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa

Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates

May 8, 2025, 6:30 AM EDT - 6 months ago

Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates

Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates

Mar 25, 2025, 6:30 AM EDT - 7 months ago

Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates

Zura Bio to Present at the Leerink Partners Global Healthcare Conference

Feb 24, 2025, 6:30 AM EST - 8 months ago

Zura Bio to Present at the Leerink Partners Global Healthcare Conference

Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

Dec 23, 2024, 6:30 AM EST - 10 months ago

Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 6:30 AM EST - 11 months ago

Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis

Nov 14, 2024, 4:30 PM EST - 1 year ago

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Nov 7, 2024, 6:30 AM EST - 1 year ago

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Zura Bio to Participate in Two Upcoming Investor Conferences in November

Oct 30, 2024, 6:30 AM EDT - 1 year ago

Zura Bio to Participate in Two Upcoming Investor Conferences in November

CPS HR Consulting Partners with GovInvest to Revolutionize Compensation Consulting with Advanced Technology

Sep 3, 2024, 6:00 AM EDT - 1 year ago

CPS HR Consulting Partners with GovInvest to Revolutionize Compensation Consulting with Advanced Technology

OGI

Zura Bio to Present at Three Upcoming Investor Conferences in September

Sep 3, 2024, 6:00 AM EDT - 1 year ago

Zura Bio to Present at Three Upcoming Investor Conferences in September

Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 13, 2024, 9:21 AM EDT - 1 year ago

Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants

Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants

Aug 9, 2024, 4:05 PM EDT - 1 year ago

Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants

Zura Bio Commences Warrant Exchange Offer and Consent Solicitation

Jul 12, 2024, 6:10 AM EDT - 1 year ago

Zura Bio Commences Warrant Exchange Offer and Consent Solicitation

Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024

Jun 14, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024

Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology

Jun 6, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology

Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024

Jun 3, 2024, 6:00 AM EDT - 1 year ago

Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024

Zura Bio Announces Participation in June Investor Conferences

May 29, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Announces Participation in June Investor Conferences

Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 9, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights

Zura Bio Announces Oversubscribed $112.5 Million Private Placement

Apr 18, 2024, 9:22 AM EDT - 1 year ago

Zura Bio Announces Oversubscribed $112.5 Million Private Placement

Zura Bio Announces Robert Lisicki as CEO and Director

Apr 8, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Announces Robert Lisicki as CEO and Director

Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer

Mar 28, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer

Zura Bio Announces Participation at March Conferences

Mar 4, 2024, 6:00 AM EST - 1 year ago

Zura Bio Announces Participation at March Conferences

Zura Bio Announces Participation at February Investor Conferences

Feb 2, 2024, 6:00 AM EST - 1 year ago

Zura Bio Announces Participation at February Investor Conferences

Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO

Jan 8, 2024, 6:00 AM EST - 1 year ago

Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO

Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit

Jan 3, 2024, 6:00 AM EST - 1 year ago

Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit

Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok

Dec 4, 2023, 6:00 AM EST - 2 years ago

Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok

Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors

Nov 14, 2023, 6:00 AM EST - 2 years ago

Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors

Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Nov 13, 2023, 6:30 AM EST - 2 years ago

Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute

Sep 12, 2023, 5:00 AM EDT - 2 years ago

Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute

Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Aug 14, 2023, 7:00 AM EDT - 2 years ago

Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Zura Bio to Join the Russell 2000® and Russell 3000® Indexes

Jun 23, 2023, 6:30 AM EDT - 2 years ago

Zura Bio to Join the Russell 2000® and Russell 3000® Indexes

Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist

Jun 6, 2023, 4:00 AM EDT - 2 years ago

Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist

Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases

Apr 27, 2023, 7:39 AM EDT - 2 years ago

Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases

Zura Bio Announces Appointment of Chief Scientific Officer

Apr 14, 2023, 5:00 AM EDT - 2 years ago

Zura Bio Announces Appointment of Chief Scientific Officer

Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp

Mar 21, 2023, 6:13 AM EDT - 2 years ago

Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp

JATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio Limited

Mar 16, 2023, 4:17 PM EDT - 2 years ago

JATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio Limited

invinc1ble
invinc1ble Oct. 25 at 3:26 PM
$ZURA sleeper. Watch it
0 · Reply
octavia8
octavia8 Oct. 14 at 2:00 PM
$ZURA v shaped recovery??
0 · Reply
jerry_berlin
jerry_berlin Oct. 13 at 3:53 PM
$ZURA why is it going down?
2 · Reply
TraderJay85
TraderJay85 Oct. 10 at 5:34 PM
$ZURA Big win! 🔥 🔥 Went to 4.58. Got in early. We had over 10 poppers so far today. If you are not hitting at least 3 runners a day, then you aint doin something right. NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 10 at 1:01 PM
$ZURA
1 · Reply
kkbb
kkbb Oct. 10 at 12:32 PM
$ZURA https://investors.zurabio.com/node/9026/html Zura Bio’s CEO, Robert Lisicki, is taking a medical leave of absence effective October 10, 2025. The company’s COO and Chief Legal Officer, Kim Davis, has been appointed interim CEO while continuing her current roles.
0 · Reply
stockthoughts9282
stockthoughts9282 Oct. 9 at 5:00 PM
I bought two shares of $ZURA last year just because I thought the name sounded funny and obviously I now wish I'd bought hundreds, because it's up 150%. What exactly do they produce or do? Can someone explain? Or is this just a pump and dump on a penny stock? Thanks.
1 · Reply
jerry_berlin
jerry_berlin Oct. 8 at 7:28 PM
$ZURA yes beauty slow and stady✨
0 · Reply
BassmanOH
BassmanOH Oct. 8 at 2:39 AM
$ZURA Complete and Utter WOW
1 · Reply
jerry_berlin
jerry_berlin Oct. 7 at 4:43 PM
$ZURA Slow and stady 🐂💚
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 6 at 7:55 PM
$MLTX switch to $ZURA . Thank Me in 5 days.
1 · Reply
deniz100
deniz100 Oct. 6 at 6:54 PM
$ZURA consolidating for $8
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 6 at 6:30 PM
$MLTX at least add $ZURA on your watchlist.
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 6 at 6:26 PM
$ZURA the volume last week was huge. Highest ever weekly volume. This is not done. Far from it! Lock in and see you at 30+.
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 6 at 6:14 PM
$MLTX final call for $ZURA
0 · Reply
TraderJay85
TraderJay85 Oct. 6 at 4:06 PM
$BTQ went to 8.59 so far. 🔥 $ZURA holding $MSS holding got in early. We had 10 poppers so far today. If you are not hitting at least 3 runners a day, then you aint doin something right. NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 6 at 3:48 PM
$ZURA looking great imo.
0 · Reply
Great_Stuff_coming
Great_Stuff_coming Oct. 6 at 3:02 PM
$MLTX sell and buy $ZURA
0 · Reply
martinimagic11
martinimagic11 Oct. 6 at 2:35 PM
$ZURA
0 · Reply
graph
graph Oct. 5 at 11:48 PM
$BTQ $MSS $ZURA never listen to this clown! Looking at his message s in history: all farting
1 · Reply
TraderJay85
TraderJay85 Oct. 5 at 10:51 PM
This week watch list with support/stop. $BTQ 6.70 stop $ZURA 3.80 stop $MSS .96 stop Never hold under support. if it goes below then sell. Jump back in if it comes back to last support. NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER ❤️
2 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 12:45 AM
$ZURA: Unusual Options Activity Alerted PUT flow observed 100x contracts at Strike price of $7.5 Exp on 11/21/2025 with Premium of $38K and showing BULLISH Sentiment
0 · Reply